Return on Investment and Cost-Effectiveness of Harm Reduction Program in Malaysia

Cases of human immunodeficiency virus (HIV) infections were first detected in Malaysia in 1986. Since then, the number of new HIV cases has been increasing steadily to a peak of 6,978 new cases detected in 2002 then declining to 3,438 new cases in...

Full description

Bibliographic Details
Main Authors:	Naning, Herlianna, Kerr, Cliff, Kamarulzaman, Adeeba, Osornprasop, Sutayut, Dahlui, Maznah, Ng, Chiu-Wan, Wilson, David P.
Format:	Working Paper
Language:	English en_US
Published:	Washington, DC 2014
Subjects:	ACQUIRED IMMUNE DEFICIENCY SYNDROME ACQUIRED IMMUNODEFICIENCY SYNDROME ADDICTION AID AMPHETAMINES ARI BLOOD TRANSFUSION CANCERS CAUSES OF DEATH CERVICAL CANCER CHILDHOOD CIRCUMCISION CITIZENS CLINICAL PROTOCOLS CLINICS CONDOMS COST EFFECTIVENESS CRIME CURRENT POPULATION DEATH RATE DEATH RATES DEATHS DECISION MAKING DEPENDANTS DEVELOPING COUNTRIES DIAGNOSES DISABILITY DISEASE DISEASE BURDEN DISEASE CONTROL DISEASE TRANSMISSION DRUG ADDICTION DRUG USERS DRUGS EPIDEMIC EPIDEMIOLOGY EXPENDITURES FEMALE GENDER GENERAL PRACTITIONER GENERIC DRUGS GLOBAL CONSENSUS GOVERNMENT AGENCIES GPS GROSS DOMESTIC PRODUCT HARM REDUCTION HEALTH CARE HEALTH CARE COSTS HEALTH CARE FACILITIES HEALTH CARE RESEARCH HEALTH CARE SERVICES HEALTH COSTS HEALTH FACILITIES HEALTH SECTOR HEALTH SERVICES HEALTH STRATEGY HEPATITIS HEPATITIS C HIV HIV INFECTION HIV INFECTIONS HIV POSITIVE HIV PREVENTION HIV TESTING HIV TRANSMISSION HIV/AIDS HOSPITAL HOSPITALS HUMAN IMMUNODEFICIENCY VIRUS HUMAN RESOURCES HYGIENE ILLNESS IMMUNE DEFICIENCY IMMUNODEFICIENCY IMPORTANT POLICY INCOME INFECTION RATE INFECTIOUS DISEASES INFORMATION SYSTEM INPATIENT CARE INTEGRATION INTERVENTION INTRAVENOUS DRUG USE ISOLATION JOB OPPORTUNITIES MALARIA MALES MEDICAL PRACTITIONERS METHADONE MINISTRY OF HEALTH MORBIDITY MORTALITY MOTHER MOTHER TO CHILD MOVEMENT OF PEOPLE NATIONAL AIDS NATIONAL DRUG NATIONAL LEVEL NATIONAL POLICY NUMBER OF NEW INFECTIONS NUMBER OF PEOPLE OPPORTUNISTIC INFECTIONS OUTPATIENT CARE OUTPATIENT SERVICES PAP SMEAR PATIENT PATIENTS POLICY DISCUSSIONS POPULATION DATA POPULATION SIZE PREVALENCE PREVENTION ACTIVITIES PRISONS PROBABILITY PROGRESS PUBLIC DEMAND PUBLIC HEALTH PUBLIC HEALTH CARE PUBLIC HEALTH SERVICES PUBLIC SERVICES PUBLIC SUPPORT QUALITY OF LIFE QUALITY OF SERVICES REHABILITATION REHABILITATION CENTRES RESOURCE ALLOCATIONS RESOURCE NEEDS RESPECT SCREENING SERVICE PROVIDERS SEX SEX WITH MEN SEX WORKERS SOCIAL CONSEQUENCES SPECIALIST SYMPTOMS SYRINGES TB TECHNICAL ASSISTANCE THERAPIES THERAPY TREATMENT USER FEES VACCINATION VIRUS INFECTIONS VOLUNTARY COUNSELLING
Online Access:	http://documents.worldbank.org/curated/en/2014/01/19533085/return-investment-cost-effectiveness-harm-reduction-program-malaysia http://hdl.handle.net/10986/18641

Internet

http://documents.worldbank.org/curated/en/2014/01/19533085/return-investment-cost-effectiveness-harm-reduction-program-malaysia
http://hdl.handle.net/10986/18641

Return on Investment and Cost-Effectiveness of Harm Reduction Program in Malaysia

Internet

Similar Items